Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery

Human Gene Therapy

Volumn 17, Issue 5, 2006, Pages 545-555

  Bledsoe, Grant ^a   Shen, Bo ^a   Yao, Yuyu ^a   Zhang, Jenny J ^a   Chao, Lee ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BRADYKININ B2 RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; ICATIBANT; INTERCELLULAR ADHESION MOLECULE 1; KALLIKREIN; KININ; NITRIC OXIDE; PROTEIN P21; PROTEIN P27; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RETICULIN; SODIUM CHLORIDE; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; INFLAMMATION; KALLIKREIN KININ SYSTEM; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY TUBULE; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PROTEIN URINE LEVEL; RAT; RAT STRAIN; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM;

ACTINS; ANIMALS; BLOOD UREA NITROGEN; COLLAGEN; FIBROSIS; GENE THERAPY; HYPERTROPHY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; KIDNEY GLOMERULUS; MALE; MULTIENZYME COMPLEXES; MYOBLASTS, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, INBRED DAHL; RETICULIN; TISSUE KALLIKREINS; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE;

EID: 33646940681     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.545     Document Type: Article

References (42)

1. ALFIE, M.E., SIGMON, D.H., POMPOSIELLO, S.I., and CARRETERO, O.A. (1997). Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension 29, 483-487.
2. BHOOLA, K.D., FIGUEROA, C.D., and WORTHY, K. (1992). Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
3. CHAO, J., ZHANG, J.J., LIN, K.F., and CHAO, L. (1998a). Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney Int. 54, 1250-1260.
4. CHAO, J., ZHANG, J.J., LIN, K.F., and CHAO, L. (1998b). Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Hum. Gene Ther. 9, 21-31.
5. CHEN, P.Y., ST JOHN, P.L., KIRK, K.A., ABRAHAMSON, D.R., and SANDERS, P.W. (1993). Hypertensive nephrosclerosis in the Dahl/Rapp rat. Initial sites of injury and effect of dietary L-arginine supplementation. Lab. Invest. 68, 174-184.
6. CLANCY, R.M., LESZCZYNSKA-PIZIAK, J., and ABRAMSON, S.B. (1992). Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90, 1116-1121.
7. COUTURE, R., HARRISSON, M., VIANNA, R.M., and CLOUTIER, F. (2001). Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 429, 161-176.
8. CRAVEN, P.A., STUDER, R.K., FELDER, J., PHILLIPS, S., and DERUBERTIS, F.R. (1997). Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells. Diabetes 46, 671-681.
9. DOBRZYNSKI, E., YOSHIDA, H., CHAO, J., and CHAO, L. (1999). Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats. Immunopharmacology 44, 57-65.
10. EDDY, A.A. (2000). Molecular basis of renal fibrosis. Pediatr. Nephrol. 15, 290-301.
11. FUJII, H., ICHIMORI, K., HOSHIAI, K., and NAKAZAWA, H. (1997). Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J. Biol. Chem. 272, 32773-32778.
12. GORDON, H., and SWEETS, H.H. (1936). A simple method for the silver impregnation of reticulum. Am. J. Pathol. 12, 545-551.
13. GRIENDLING, K.K., MINIERI, C.A., OLLERENSHAW, J.D., and ALEXANDER, R.W. (1994). Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148.
14. HIRAWA, N., UEHARA, Y., SUZUKI, T., KAWABATA, Y., NUMABE, A., GOMI, T., IKEDA, T., KIZUKI, K., and OMATA, M. (1999). Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B2-receptor-mediated event. Nephron 81, 183-193.
15. JIN, L., ZHANG, JJ., CHAO, L., and CHAO, J. (1997). Gene therapy in hypertension: Adenovirus-mediated kallikrein gene delivery in hypertensive rats. Hum. Gene Ther. 8, 1753-1761.
16. JUNQUEIRA, L.C., BIGNOLAS, G., and BRENTANI, R.R. (1979). Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11, 447-455.
17. KALLURI, R., and NEILSON, E.G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784.
18. 1. Cell Growth Differ. 10, 621-628.
19. MARTIN, A., ESCUDERO, E., and MAMPASO, F. (1997). Role of leucocyte adhesion molecules in aminonucleoside of puromycin (PAN)-associated interstitial nephritis. Clin. Exp. Immunol. 108, 78-87.
20. MATSUO, S., MORITA, Y., MARUYAMA, S., MANCHANG, L., and YUZAWA, Y. (2003). Proteinuria and tubulointerstitial injury: The causative factors for the progression of renal diseases. Contrib. Nephrol. 139, 20-31.
21. McMANUS, J.F. (1948). Histological and histochemical uses of periodic acid. Stain Technol. 23, 99-108.
22. MISKO, T.P., SCHILLING, R.J., SALVEMINI, D., MOORE, W.M., and CURRIE, M.G. (1993). A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214, 11-16.
23. MONKAWA, T., HIROMURA, K., WOLF, G., and SHANKLAND, S.J. (2002). The hypertrophic effect of transforming growth factor-β is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27. J. Am. Soc. Nephrol. 13, 1172-1178.
24. MURAKAMI, H., YAYAMA, K., CHAO, L., and CHAO, J. (1998). Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats. Kidney Int. 53, 1305-1313.
25. NAICKER, S., NAIDOO, S., RAMSAROOP, R., MOODLEY, D., and BHOOLA, K. (1999). Tissue kallikrein and kinins in renal disease. Immunopharmacology 44, 183-192.
26. REGOLI, D., RHALEB, N.E., DRAPEAU, G., and DION, S. (1990). Kinin receptor subtypes. J. Cardiovasc. Pharmacol. 15(Suppl. 6), S30-S38.
27. RODRIGUEZ-ITURBE, B., VAZIRI, N.D., HERRERA-ACOSTA, J., and JOHNSON, R.J. (2004). Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: All for one and one for all. Am. J. Physiol. Renal Physiol. 286, F606-F616.
28. SCHANSTRA, J.P., NEAU, E., DROGOZ, P., AREVALO GOMEZ, M.A., LOPEZ NOVOA, J.M., CALISE, D., PECHER, C., BADER, M., GIROLAMI, J.P., and BASCANDS, J.L. (2002). In vivo bradykinin B2 receptor activation reduces renal fibrosis. J. Clin. Invest. 110, 371-379.
29. SHANKLAND, S.J., and WOLF, G. (2000). Cell cycle regulatory proteins in renal disease: Role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol. Renal Physiol. 278, F515-F529.
30. SHARMA, K., JIN, Y., GUO, J., and ZIYADEH, F.N. (1996). Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45, 522-530.
31. SPIECKER, M., DARIUS, H., KABOTH, K., HUBNER, F., and LIAO, J.K. (1998). Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukoc. Biol. 63, 732-739.
32. TROLLIET, M.R., RUDD, M.A., and LOSCALZO, J. (2001). Oxidative stress and renal dysfunction in salt-sensitive hypertension. Kidney Blood Press. Res. 24, 116-123.
33. UEHARA, Y., HIRAWA, N., KAWABATA, Y., SUZUKI, T., OHSHIMA, N., OKA, K., IKEDA, T., GOTO, A., TOYO-OKA, T., KIZUKI, K., and OMATA, M. (1994). Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension 24, 770-778.
34. WANG, C., CHAO, C., CHEN, L.M., CHAO, L., and CHAO, I. (1996). High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats. Am. J. Physiol. 271, F824-F830.
35. WEINBERGER, M.H. (1996). Salt sensitivity of blood pressure in humans. Hypertension 27, 481-490.
36. WOLF, G., and STAHL, R.A. (1996). Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1. Kidney Int. 50, 2112-2119.
37. WU, J.C., FAN, G.M., KITAZAWA, K., and SUGISAKI, T. (1996). The relationship of adhesion molecules and leukocyte infiltration in chronic tubulointerstitial nephritis induced by puromycin aminonucleoside in Wistar rats. Clin. Immunol. Immunopathol. 79, 229-235.
38. XIA, C.F., YIN, H., BORLONGAN, C.V., CHAO, L., and CHAO, I. (2004). Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43, 452-459.
39. 1 and nitric oxide is altered in salt-sensitive hypertension. Am. J. Physiol. Renal Physiol. 285, F902-F908.
40. YOSHIDA, H., ZHANG, J.J., CHAO, L., and CHAO, J. (2000). Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35, 25-31.
41. YU, H., SONG, Q., FREEDMAN, B.I., CHAO, J., CHAO, L., RICH, S.S., and BOWDEN, D.W. (2002). Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int. 61, 1030-1039.
42. ZHANG, J.J., BLEDSOE, G., KATO, K., CHAO, L., and CHAO, J. (2004). Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney Int. 66, 722-732.